| Gene name: | TNFSF13 |
| Aging type: | Prevent |
| Aging characteristic: |
| Tissue type: | -- |
| Cell name: | SW480 |
| Gene ID: | 8741 |
| Category: | protein coding |
| Phenotype: | Colorectal cancer |
| Experimental category: | L |
| PMID: | 19466596 |
| Experiment: | SA-β-gal activity assay |
| Description: | These results indicated cellular β-galactosidase activity, a symbol of cell ageing, had enhanced compare with that of no pGshAPRIL-transfection. |
| Regulatory pathway: | HSPG |
| R-AG-Pathway: | -- |
| Official symbol(s): | HSPG2 |
| Pathway experiment: | Western blot//SA-β-gal activity assay |
| Pathway description: | By contrast, high levels of SA-β-gal activity were exhibited in pGshAPRIL-transfected plus TACI-Fctreated groups or those transfected with pGshAPRIL (P< 0.01). SA-β-gal activity was shown to increase in groups with pGshAPRIL and heparin combined treatment and so did in pGshAPRIL, TACI-Fc add heparin treatment groups (P<0.05). |
Annotation:
Loading,please wait...